Privacy Policy
Signals Blog

Contributors

Categories

Bioprocessing and bioanalytics

by | Nov 30, 2017

The recent FDA approvals of Kymriah™ for the treatment of children and young adults with B-cell Acute Lymphoblastic Leukemia, and Yescarta™ to treat adults with certain types of non-Hodgkin lymphoma, and the unanimous endorsement by an FDA advisory committee of a gene...